The role of aldosterone antagonism agents in diabetic kidney disease

ConclusionAldosterone antagonism may represent a safe and effective complimentary therapy to the use of angiotensin converting enzyme inhibition, or angiotensin receptor blockade, for slowing the progression of diabetic kidney disease.

Source: Journal of Renal Care - September 1, 2014 Category: Urology & Nephrology Authors: Eric Wombwell, Andrew Naglich Tags: Review Article Source Type: research